Literature DB >> 14616349

Treatment of Bowen's disease and erythroplasia of Queyrat.

J P Arlette1.   

Abstract

Bowen's disease of the skin may have differing clinical presentations depending on the skin surface on which it presents, but has the same histologic features of squamous cell carcinoma in situ wherever it occurs. The etiologic factors include ultraviolet light and human papillomavirus infection. The choice of therapy requires a consideration for retention of form, function and cosmosis while offering a high cure rate. The immunodualtory agent imiquimod has been shown to be an effective treatment on a variety of skin surfaces.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14616349     DOI: 10.1046/j.0366-077x.2003.05635.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

Review 1.  [Therapeutic options for epithelial skin tumors. Actinic keratoses, Bowen disease, squamous cell carcinoma, and basal cell carcinoma].

Authors:  R-M Szeimies; S Karrer; H Bäcker
Journal:  Hautarzt       Date:  2005-05       Impact factor: 0.751

2.  [Precancerous tumors and carcinomas in situ of the skin].

Authors:  D Krüger-Corcoran; S Vandersee; E Stockfleth
Journal:  Internist (Berl)       Date:  2013-06       Impact factor: 0.743

3.  A case of erythroplasia of queyrat treated with imiquimod 5% cream and excision.

Authors:  Jee Woong Choi; Mira Choi; Kwang Hyun Cho
Journal:  Ann Dermatol       Date:  2009-11-30       Impact factor: 1.444

Review 4.  Erythroplasia of Queyrat treated by laser and light modalities: a systematic review.

Authors:  Eric L Maranda; Austin H Nguyen; Victoria M Lim; Vidhi V Shah; Joaquin J Jimenez
Journal:  Lasers Med Sci       Date:  2016-06-21       Impact factor: 3.161

5.  Bowen's disease - a review of newer treatment options.

Authors:  Thorsten Neubert; Percy Lehmann
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.